Position in ALVO
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$31,658
-$42,054 QoQ
Shares Held
9,230
-35.8% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026CITIGROUP INC holds $466,878,193 across 57 Drug Manufacturers - Specialty & Generic names. ALVO ranks #42 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
235,620 | $139,717,946 | |
| 2 | ZTS |
Zoetis Inc.
|
1,130,742 | $133,665,010 | |
| 3 | VTRS |
Viatris Inc
|
3,966,552 | $53,588,116 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
832,323 | $25,069,568 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
112,442 | $14,813,107 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
662,928 | $13,762,384 | |
| 7 | HLN |
Haleon plc
|
1,329,934 | $13,312,638 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
160,225 | $12,153,065 |
All Filings in ALVO
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $31,658 | 9,230 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $73,712 | 14,369 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $49,295 | 6,019 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $46,375 | 5,085 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $42,422 | 4,387 | Shares | Defined | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||